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Most (90–100%) vitamin D is produced
endogenously following solar ultraviolet radia-
tion (UVR) of precursors within sun-exposed
skin (Holick 1994). Only a few foods, such as
oily fish, contain significant amounts of vita-
min D naturally (Holick 1994). Serum
25-hydroxyvitamin D [25(OH)D] is widely
recognized as the best measure of vitamin D
status (Holick 2004a), and reflects UVR expo-
sure and vitamin D intake of the previous few
months (Vieth 1999). In the absence of dietary
fortification, vitamin D intake in Australia is
low, varying from 1.2 to 2.6 μg/day (Nowson
and Margerison 2002). This is much lower
than the recommended dietary intake
(5 μg/day for those 0–50 years of age,
10 μg/day for those 51–70 years, 15 μg/day for
those > 70 years) (Commonwealth of Australia
2006) or the estimated intake of 10–15 μg/day
required to obtain serum 25(OH)D levels of
50 nmol/L (Dawson-Hughes et al. 2005).
Vitamin D status is often defined by serum
levels of 25(OH)D as follows: vitamin D defi-
ciency, 25(OH)D < 25 nmol/L; vitamin D
insufficiency, 25(OH)D of 25–50 nmol/L;
and optimal status, 25(OH)D > 50 nmol/L
(Nowson and Margerison 2002; Vieth et al.
2001). Recent evidence suggests that the opti-
mal serum 25(OH)D levels may be even
higher, > 80 nmol/L (Dawson-Hughes et al.
2005; Hollis 2005). 
A balance is required in the amount of
personal UVR exposure. Excessive sun expo-
sure has been associated with increased risk of
cutaneous malignant melanoma, non-
melanoma skin cancers, and some cataracts
(Lucas et al. 2006); however, low UVR expo-
sure can result in vitamin D deficiency or
insufficiency. It has been well established that
vitamin D is essential to bone health, with low
levels associated with rickets, osteoporosis, and
osteomalacia (Holick 2004b). Vitamin D
insufficiency causes muscle weakness and may
contribute to falls in the elderly, which—
when associated with osteoporosis—increases
the likelihood of fractures. However, more
recent evidence indicates that vitamin D
insufficiency might also be associated with
diseases such as colorectal cancer, prostate
cancer, multiple sclerosis (MS), type 1 dia-
betes, cardiovascular diseases, and tuberculo-
sis (Hughes et al. 2004; Hypponen et al.
2001; Luscombe et al. 2001; van der Mei
et al. 2003; Zittermann 2003). 
The “sun smart” public health messages,
aimed at reducing skin cancer, have been suc-
cessful, partly because of their simplicity.
However, there is increasing awareness that
any simple public health message of sun avoid-
ance may cause harm by increasing vitamin D
insufficiency (Grant et al. 2005; Sinclair
2006). A more balanced approach is now
being taken, and new public health messages
are being developed that provide a more tai-
lored approach concerning factors such as lati-
tude, time of year, skin type, and age (Holick
2004b; Samanek et al. 2006; Working Group
of the Australian and New Zealand Bone and
Mineral Society, Endocrine Society of
Australia, and Osteoporosis Australia 2005).
Tools, such as the UV Index [based on a
weighting of UV irradiances that produce ery-
thema (i.e., sunburn)] are being used to iden-
tify the appropriate times of the year or day
that sun protection is most important (Sinclair
2006). The World Health Organization
(WHO 2007) and the Cancer Council
Australia (2007) currently recommend that
protective measures should be taken (e.g., use
of a hat, sunscreen, or sunglasses; seek shady
areas) when the UV index is ≥ 3. In addition,
recommended solar UVR exposure periods to
maintain vitamin D sufficiency have been cal-
culated at different locations based on ambient
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BACKGROUND: Inadequate sun exposure and dietary vitamin D intake can result in vitamin D
insufficiency. However, limited data are available on actual vitamin D status and predictors in
healthy individuals in different regions and by season. 
METHODS: We compared vitamin D status [25-hydroxyvitamin D; 25(OH)D] in people < 60 years
of age using data from cross-sectional studies of three regions across Australia: southeast
Queensland (27°S; 167 females and 211 males), Geelong region (38°S; 561 females), and
Tasmania (43°S; 432 females and 298 males). 
RESULTS: The prevalence of vitamin D insufficiency (≤ 50 nmol/L) in women in winter/spring was
40.5% in southeast Queensland, 37.4% in the Geelong region, and 67.3% in Tasmania. Season,
simulated maximum daily duration of vitamin D synthesis, and vitamin D effective daily dose each
explained around 14% of the variation in 25(OH)D. Although latitude explained only 3.9% of the
variation, a decrease in average 25(OH)D of 1.0 (95% confidence interval, 0.7–1.3) nmol/L for
every degree increase in latitude may be clinically relevant. In some months, we found a high insuf-
ficiency or even deficiency when sun exposure protection would be recommended on the basis of
the simulated ultraviolet index. 
CONCLUSION: Vitamin D insufficiency is common over a wide latitude range in Australia. Season
appears to be more important than latitude, but both accounted for less than one-fifth of the varia-
tion in serum 25(OH)D levels, highlighting the importance of behavioral factors. Current sun
exposure guidelines do not seem to fully prevent vitamin D insufficiency, and consideration should
be given to their modification or to pursuing other means to achieve vitamin D adequacy.
KEY WORDS: 25(OH)D, behavior, latitude, UV index, UVR, vitamin D, vitamin D index. Environ
Health Perspect 115:1132–1139 (2007). doi:10.1289/ehp.9937 available via http://dx.doi.org/
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UVR (assuming sufficiency is maintained by
one-third of a minimal erythemal dose of sun-
light for an individual with moderately fair
skin who exposes 15% of the body (e.g., face,
arms, hands) (Samanek et al. 2006). This
information is important, but a stronger evi-
dence base is required on the actual serum
25(OH)D status in different regions and by
season, reflecting interindividual differences in
sun exposure behaviors and other factors,
rather than the predicted serum 25(OH)D sta-
tus from ambient UVR alone. 
We pooled population-based samples of
individuals < 60 years of age with serum meas-
urements of 25(OH)D across a broad latitudi-
nal range in Australia [southeast Queensland,
27°S; the Geelong region (specifically the
Barwon Statistical Division), 38°S; and
Tasmania, 43°S] (McGrath et al. 2001b; Pasco
et al. 2001; van der Mei et al. 2007). We also
included new data on a large population-based
sample from Tasmania [the Tasmanian Older
Adult Cohort (TasOAC) study]. In the present
study, we aimed to a) examine the prevalence
of vitamin D deficiency and insufficiency by
season at each of the three locations; b) exam-
ine differences in the seasonal variation
between the three locations in terms of the
timing of the peak and the trough, the magni-
tude of the amplitude of the seasonal variation
and the estimated mean, peak, and trough
25(OH)D values; and c) examine to what
extent actual serum 25(OH)D levels are pre-
dicted by season, latitude, and the maximum
daily duration of vitamin D synthesis in human
skin, and vitamin D effective daily dose.
Methods
Participants. In this study we used data from
three published studies (McGrath et al. 2001b;
Pasco et al. 2001; van der Mei et al. 2007) and
the TasOAC study, covering three regions and
including subjects in varying age ranges. All of
these studies included participants < 60 years
of age and provided a good sample of young
and middle-aged adults. 
Southeast Queensland. A case–control
study on psychosis was conducted in southeast
Queensland from 1997 to 1999 and included
310 cases and 303 controls (McGrath et al.
2001a, 2002). All subjects provided written
informed consent, and the study was approved
by the Wolston Park Hospital Institutional
Ethics Committee. For the present study, we
selected only those subjects < 60 years of age
(167 women and 211 men) for whom serum
25(OH)D levels were available.
Geelong region. In the Geelong region (in
southern Victoria), an age-stratified, random,
population-based sample of women (n = 1,494)
was recruited from Commonwealth Electoral
Rolls (1993–1997), with a response rate of
77.1% (Henry et al. 2000; Pasco et al. 2000).
Of the subjects of the original study, 99% were
white, and none were shrouded for religious
reasons. Written informed consent was
obtained from all participants, and the project
was approved by the Barwon Health Human
Research and Ethics Committee. For the pre-
sent study, we used data only from the women
< 60 years of age if they were free from expo-
sure to drugs and diseases known to influence
calcium metabolism (n = 561).
Tasmania. In Tasmania, control partici-
pants from the Tasmanian MS case–control
study (1999–2001) (van der Mei et al. 2003)
and participants from the TasOAC study
(2002–2004) were included. The controls
from the Tasmanian MS case–control study
(van der Mei et al. 2003) (n = 272; response
rate 76%) were randomly drawn from the
Tasmanian Electoral Roll and matched on
sex and birth year to prevalent MS cases
< 60 years of age. Data from 174 women and
88 men with serum 25(OH)D were available.
The TasOAC study included participants
50–80 years of age randomly selected from
the Tasmanian Electoral Roll (response rate
54%); all participants < 60 years of age
(258 women and 211 men) were included.
Written informed consent was obtained from
all participants, and the projects were
approved by the Human Research Ethics
Committee of the Royal Hobart Hospital. 
Measurements and simulations. For the
present study, the following data were available
at an individual level for all of the studies:
serum 25(OH)D, date of serum sample collec-
tion, date of birth, and sex. In all studies,
serum 25(OH)D was measured using a radio-
immunoassay kit (DiaSorin, Stillwater, MN,
USA) (McGrath et al. 2001b; Pasco et al.
2001; van der Mei et al. 2007). The intraassay
and interassay precisions of these assays are 6%
and 15%, respectively. Of the four studies,
only participants in the TasOAC study in
Tasmania provided information on the
amount of time spent in the sun during week-
ends and holidays in the past winter and sum-
mer (< 1 hr/day, 1–2 hr/day, 2–3 hr/day,
3–4 hr/day, or > 4 hr/day). 
For each of the three locations, we used the
VitD methodology of Engelsen et al. (2005) to
estimate maximum daily duration of vitamin D
synthesis in human skin, vitamin D effective
daily dose, and the UV index for each day in
the years that the four studies were conducted.
Maximum daily duration of vitamin D synthe-
sis in human skin is the time per day in hours
in which UVR exceeds the threshold required
to produce vitamin D (Brustad et al. 2004;
Webb et al. 1988). Vitamin D effective daily
dose is the daily dose of UVR wavelengths rele-
vant to the conversion of 7-dehydrocholesterol
into previtamin D in the skin, based on the
vitamin D action spectrum (MacLaughlin
et al. 1982). This is important because the
action spectrum to produce previtamin D is
different from the action spectrum that pro-
duces erythema (sunburn). 
First, using the method of MacLaughlin
et al. (1982), we established a biologically
effective UV dose rate for photoconversion of
7-dehydrocholesterol to previtamin D in skin
by integrating the measured UV surface irra-
diances weighted by the relative efficiencies
for converting 7-dehydrocholesterol to previt-
amin D. Then, the biologically effective dose
was integrated over a full day to estimate the
vitamin D effective daily dose. The UV index
(WHO 2002) gives an indication of the UV
intensity at solar noon using the action spec-
trum to produce erythema. The daily values
were calculated without rounding to nearest
integer, but the monthly mean values were
rounded to the nearest integer.
To estimate UV irradiances, taking ozone
levels into account, we used the VitD method-
ology of Engelsen et al. (2005). Satellite
ozone data from the Total Ozone Mapping
Spectrometer (TOMS) were used for Brisbane
(for southeast Queensland), Aspendale (for the
Geelong region), and Hobart (for Tasmania).
From 25 November 1994 to 24 July 1996, no
TOMS satellite instruments were in opera-
tion. Because the Geelong study was con-
ducted during this period, the TOMS ozone
series for the Geelong region was comple-
mented with Dobson ozone measurements
from Melbourne Airport. All remaining total
ozone data gaps were filled using linear inter-
polation. We assumed a dry concrete surface
at sea level and a cloudless atmosphere with a
surface visibility of 25 km. All other remaining
model parameters used for the simulations of
UV radiation were fixed and identical to those
reported by Engelsen et al. (2005). 
Statistical analysis. Because the sample in
the Geelong region consisted of women only,
most analyses were restricted to women; how-
ever, in some instances, comparisons were
made with men. Tests for differences of the
mean age by location or serum 25(OH)D lev-
els by sex were performed using analysis of
variance (ANOVA). In southeast Queensland,
half the sample had a diagnosis of psychosis,
but we found no difference in mean
25(OH)D between the groups with and with-
out that diagnosis (p = 0.98) (McGrath et al.
2001b). The prevalence of vitamin D defi-
ciency or insufficiency was calculated using
commonly used cut-points (≤ 25 nmol/L and
≤ 50 nmol/L, respectively) (Nowson and
Margerison 2002; Vieth et al. 2001). We also
used ≤ 60 nmol/L and ≤ 80 nmol/L as cut-
points, because there is an increasing debate
whether optimal serum 25(OH)D levels
might be > 50 nmol/L (Dawson-Hughes et al.
2005; Hollis 2005). We used logistic regres-
sion to examine whether the prevalence of
vitamin D insufficiency or deficiency differed
by latitude by including the actual latitude of
Vitamin D insufficiency across Australian populations
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each of the regions as a predictor. We adjusted
for season by including binary (0, 1) terms for
three of the four seasons (summer, autumn,
winter, and spring). 
To model the seasonal variation of serum
25(OH)D, we fitted a sinusoidal model to the
actual serum 25(OH)D levels and the month
the sample was taken (t):
.
[1]
With the same method we modeled the sea-
sonal variation of simulated daily duration of
vitamin D synthesis and simulated vitamin D
effective daily dose. We used the ANOVA
F-test to determine whether the seasonal vari-
ation was significant, and we calculated the
amplitude using the formula
.
[2]
The peak and trough were found by taking
the first derivative of the sinusoidal function
and solving for the value of t for which the
first derivative was zero. This gave the formula
.
[3]
For the test for trend of the mean serum
25(OH)D levels by location, we tested the sig-
nificance of a covariate taking latitude values
for each location (southeast Queensland = 27,
Geelong = 38, Tasmania = 43). For the test
for trend by location of the estimated mean
maximum daily duration of vitamin D synthe-
sis and vitamin D effective daily dose, we fol-
lowed the same procedure but allowing
variation in the seasonal patterns between the
three locations. For tests for trend of the esti-
mated amplitude for serum 25(OH)D, maxi-
mum daily duration of vitamin D synthesis,
and vitamin D effective daily dose, we used
meta-regression methods with precision
weighting of the point estimates and adjust-
ment of SEs using the procedure described by
Greenland (1998). To compare the seasonal
pattern in 25(OH)D in men and women, we
added a sex interaction for each of the sine and
cosine components of the sinusoidal model,
and tested the improvement in fit using a par-
tial F-test. To examine predictors of
25(OH)D, we calculated Pearson correlation
coefficients or used linear regression. For these
analyses, 25(OH)D values were transformed
to reduce skewness using a square root trans-
formation. A logarithmic transformation pro-
duced similar results (data not shown). With
linear regression, tests for interaction were
conducted using the coefficient and SE of a
product term.
Results
Table 1 shows that the sample of women in the
Geelong region was younger than the samples
in southeast Queensland (p = 0.02) and
Tasmania (p < 0.01). Serum 25(OH)D levels
were not strongly associated with age in any of
the three samples (southeast Queensland,
r = –0.02, p = 0.74; Geelong region, r = –0.08,
p = 0.07; Tasmania, r = 0.01, p = 0.81). As
expected, mean levels of serum 25(OH)D were
lower in women than in men (southeast
Queensland: women, 67.0 nmol/L and men
72.2 nmol/L, p = 0.06; Tasmania: women,
51.1 nmol/L and men, 55.2 nmol/L, p < 0.01).
Prevalence of vitamin D insufficiency and
deficiency by location and by season. Figure 1
shows the prevalence of vitamin D deficiency
and insufficiency in women by season.
Irrespective of their location across Australia,
vitamin D insufficiency was common in win-
ter and spring. For example, the prevalence of
levels ≤ 50 nmol/L in winter/spring was
40.5% for southeast Queensland, 37.4% for
the Geelong region, and 67.3% for Tasmania.
The prevalence of deficiency (< 25 nmol/L) in
women was also highest in winter and spring
(7.1% in southeast Queensland, 7.9% in the
Geelong region, and 13.0% in Tasmania). If
we define vitamin D insufficiency as levels
≤ 60 nmol/L or ≤ 80 nmol/L, respectively,
then the prevalence in winter/spring would be
as follows: southeast Queensland 54.8% and
82.1%; Geelong region, 50.2% and 74.0%;
and Tasmania, 83.7% and 97.0%.
In this sample pooled over three locations,
vitamin D insufficiency (p < 0.01, adjusted
for season) and vitamin D deficiency
(p = 0.05, adjusted for season) increased, on
average, with increasing latitude. 
In the TasOAC study in Tasmania, data
were also available on the amount of time
participants spent in the sun during weekends
and holidays in the past winter (here termed
“winter sun exposure”). People who reported
more winter sun exposure had higher levels of
serum 25(OH)D in winter (r = 0.28,
p < 0.01) and spring (r = 0.25, p = 0.02); the
prevalence of vitamin D insufficiency and
deficiency in winter/spring was also lower
among those who had most sun exposure:
Vitamin D insufficiency and deficiency were
42.9% (12/28) and 7.1% (2/28), respectively,
among those who reported on average
> 4 hr/day of sun, and 74.6% (50/67) and
t =
⎛
⎝⎜
⎞
⎠⎟
12
2
1
2π
β
βarctan
β β12 22+
25(OH)D levels =
β β π β π0 1 2212
2
1
+ +sin cos
t t
2
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Table 1. Age and season of blood sampling in population-based samples of men and women < 60 years.
Southeast Queensland Geelong region Tasmania
Females Males Females Females Males
No. (%) No. (%) No. (%) No. (%) No. (%)
Age (years)
< 20 6 (3.6) 7 (3.3) 0 (0) 0 (0) 0 (0)
20–29 34 (20.4) 41 (19.4) 162 (28.9) 17 (3.9) 1 (0.3)
30–39 38 (22.8) 65 (30.8) 177 (31.6) 45 (10.4) 21 (7.1)
40–49 49 (29.3) 61 (28.9) 144 (25.7) 67 (15.5) 34 (11.4)
50–59 40 (24.0) 37 (17.5) 78 (13.9) 303 (70.1) 242 (81.2)
Total 167 211 561 432 298
Season serum sample collected
Summer (Dec–Feb) 55 (32.9) 44 (20.9) 121 (21.6) 57 (13.2) 49 (16.4)
Autumn (Mar–May) 28 (16.8) 63 (29.9) 175 (31.2) 167 (38.7) 114 (38.3)
Winter (Jun–Aug) 27 (16.2) 24 (11.4) 136 (24.2) 103 (23.8) 77 (25.8)
Spring (Sep–Nov) 57 (34.1) 80 (37.9) 129 (23.0) 105 (24.3) 58 (19.5)
Total 167 211 561 432 298
Figure 1. Prevalence of vitamin D deficiency (≤ 25 nmol/L), vitamin D insufficiency (26–50 nmol/L), and vita-
min D sufficiency (> 50 nmol/L) for women < 60 years years of age in southeast Queensland (latitude 27°S),
Geelong (latitude 38°S), and Tasmania (41–43°S) by season.
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19.4% (13/67) among those who reported on
average < 1 hr/day of sun.
Monthly prevalence of vitamin D insuffi-
ciency and deficiency compared with UV
index. Figure 2 shows the monthly prevalence
of vitamin D insufficiency and deficiency as
well as the average monthly UV index, simu-
lated for cloudless conditions. The colors of
the bars represent the current sun protection
recommendations based on the UV index for
a cloudless day: green indicates that the UV
level is low and no or minimal protection is
required, whereas the other colors indicate
that sun protection should be used. In south-
east Queensland, there is a high prevalence of
vitamin D insufficiency in July, which is mid-
winter; however, UV protection is still recom-
mended at this time of year. In Geelong,
there is substantial vitamin D insufficiency
and deficiency during winter and spring, and
for a large part of that time sun protection is
recommended. In Tasmania, vitamin D
insufficiency and deficiency seems to be com-
mon for a large part of the year, including the
months May–August, when generally no pro-
tection is recommended.
Seasonal variation in serum 25(OH)D
levels, maximum daily duration of vitamin D
synthesis, and vitamin D effective daily dose.
Serum 25(OH)D. At each location, there was
significant seasonal variation in 25(OH)D lev-
els among women (p < 0.01) (Figure 3A,D,G).
Surprisingly, the Geelong region had the
Vitamin D insufficiency across Australian populations
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Figure 2. Prevalence of vitamin D deficiency (≤ 25 nmol/L; solid bars) and insufficiency (≤ 50 nmol/L; stippled bars) and the UV index (__) on a cloudless day by
month of the year in (A) southeast Queensland, (B) the Geelong region, and (C) Tasmania. Colors of the bars represent the current sun protection recommenda-
tions based on the UV index: green (UV index ≤ 2), can safely stay outdoors with minimal protection; yellow (UV index 3–5), wear hat, sunscreen, sunglasses, seek
shady areas; orange (UV index 6–7), see yellow and stay indoors between 1000 and 1400 hours (1100–1500 hours daylight saving time); red (UV index 8–10), see
orange and stay indoors as much as possible; blue (UV index ≥ 11), see red. 
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Figure 3. Seasonal variation in actual serum 25(OH)D levels and predicted serum 25(OH)D (solid line) (A, D, G), simulated maximum daily duration of vitamin D syn-
thesis in human skin (B, E, H), and simulated vitamin D effective daily dose (C, F, I) in southeast Queensland (A–C), the Geelong region (D–F), and Tasmania (G–I).
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highest mean 25(OH)D levels (p < 0.01 com-
pared with southeast Queensland; p < 0.01
compared with Tasmania) and the strongest
amplitude (Table 2). Southeast Queensland
had the least seasonal variation in serum
25(OH)D. As expected, Tasmania had the
lowest mean 25(OH)D level. The amplitude
of seasonal variation in men in southeast
Queensland was similar to that of the women
(mean 72.2 nmol/L, amplitude 10.6 nmol/L,
peak 80.5 nmol/L in early January, trough
59.6 nmol/L in early July). In Tasmania, the
amplitude was greater for men than for women
(p = 0.03; mean 55.2 nmol/L, amplitude 16.2
nmol/L, peak 70.5 nmol/L in mid-February,
trough 38.2 nmol/L in mid-August). 
Maximum daily duration of vitamin D
synthesis. The predicted seasonal variation of
simulated maximum daily duration of vita-
min D synthesis in human skin is shown in
Figure 3B, 3E, and 3H. Our analyses show
that southeast Queensland had the greatest
mean duration per day when UVR was such
that vitamin D production could occur
(Table 3). In addition, southeast Queensland
had the least seasonal variation over the year
(amplitude) in hours per day of vitamin D
production (Table 3). Tasmania had the low-
est mean duration per day when vitamin D
production could occur, but the greatest sea-
sonal variation over the year and the highest
number of hours of vitamin D production in
summer (peak). The time of the year of the
peaks and troughs were the same for all loca-
tions (Table 3). 
Vitamin D effective daily dose. Table 3
and Figure 3C, 3F, and 3I show the seasonality
in the daily dose of UVR effective for vitamin
D production at each location, based on the
vitamin D action spectrum for the conversion
of 7-dehydrocholesterol into previtamin D.
Although Tasmania had the highest peak for
daily hours of vitamin D production in sum-
mer compared with the other regions, the vita-
min D effective daily dose in that location was
the lowest of the three regions in summer
(Table 3, Figure 3C,F,I). This is consistent
with the known lower intensity of UVR per
hour in Tasmania. 
Multivariable analysis of serum 25(OH)D
levels. Latitude and season. For the total sam-
ple of women, we examined the contribution of
season by fitting a sinusoidal model to square
root–transformed 25(OH)D levels and the
month the serum sample was collected. Season
explained 13.6% of the variation in 25(OH)D
levels. We noted above that the effect of season
was less pronounced for southeast Queensland
than for Geelong and Tasmania, but a test of
difference of the seasonal pattern by latitude
was not significant (p = 0.21 for interaction). A
higher latitude was significantly associated with
lower serum 25(OH)D (p < 0.01). Although it
only explained 3.9% of the variation in
25(OH)D, the clinical contribution of higher
latitude seems substantial because serum
25(OH)D decreased on average by 1.0 nmol/L
(95% confidence interval, 0.7–1.3 nmol/L) for
every degree increase in latitude. Also, after
taking season into account, latitude remained
significantly associated with serum 25(OH)D
(p < 0.01). This model, including latitude and
season, predicted 16.5% of the variation in
25(OH)D levels. 
Maximum daily duration of vitamin D
synthesis and vitamin D effective daily dose.
We found a high correlation (r = 0.92)
between simulated maximum daily duration
of vitamin D synthesis in human skin and
vitamin D effective daily dose. Maximum
daily duration of vitamin D synthesis
explained 7.0% of the variation in serum
25(OH)D levels, and vitamin D effective daily
dose explained 7.8%. Shifting the data so the
estimated peaks and troughs were aligned with
the estimated peak and trough of serum
25(OH)D levels at each location made a sub-
stantial difference. After alignment, maximum
daily duration of vitamin D synthesis
explained 14.5% of the variation in serum
25(OH)D levels, and vitamin D effective daily
dose explained 14.8%. The lag time between
the estimated peak of maximum daily dura-
tion of vitamin D synthesis and the estimated
peak in serum 25(OH)D was 26 days for
southeast Queensland, 53 days for the
Geelong region, and 47 days for Tasmania.
For vitamin D effective dose, the lag times
were 21 days for southeast Queensland,
49 days for the Geelong region, and 43 days
for Tasmania. 
Interestingly, a model including maxi-
mum daily duration of vitamin D synthesis
with season and latitude did not explain much
more of the variation of serum 25(OH)D
(17.1%) than a model including season and
latitude alone (16.5%). In line with this, after
adjustment for maximum daily duration of
vitamin D synthesis and latitude, there
remains a seasonal pattern (p < 0.01), but it is
diminished. Similarly, after adjustment for the
seasonal pattern and latitude, the association
between maximum daily duration of
vitamin D synthesis and serum 25(OH)D is
significant (p < 0.01) but diminished. This
indicates that both variables partly capture the
same information. The same was true for the
analyses using vitamin D effective daily dose.
Discussion
In three population-based samples of women
< 60 years of age across Australia [southeast
Queensland (27°S), Geelong region (38°S),
and Tasmania (43°S)], vitamin D insufficiency
was common in winter and spring. Season was
a strong determinant of vitamin D status.
Simulated maximum daily duration of vitamin
D synthesis and vitamin D effective daily dose
were also important predictors of serum
25(OH)D levels after aligning the seasonal pat-
terns of those variables with seasonal pattern of
serum 25(OH)D. The contribution of latitude
was also evident but of lower magnitude. In
some months when sun exposure protection
van der Mei et al.
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Table 2. Characteristics of the seasonal variationa in serum 25(OH)D levels in population-based samples of
women < 60 years of age in southeast Queensland, the Geelong region, and Tasmania.
Estimated
Mean Amplitudeb Peak Month Trough Month 
(nmol/L) (nmol/L) (nmol/L) peak (nmol/L) trough
Southeast Queensland 67.0 10.34 75.3 Early January 54.6 Early July
Geelong region 75.5 17.7 92.5 Early February 57.1 Early August
Tasmania 51.1 10.9 62.1 Early February 40.3 Early August
Test for trend p < 0.01 p = 0.15
aA sinusoidal model was applied to the actual 25(OH)D levels and the month the serum sample was taken. bHalf the difference
between the estimated peak and trough.
Table 3. Characteristics of the estimated seasonal variationa in simulated maximum daily duration of vitamin D
synthesis in human skin and simulated vitamin D effective daily dose in southeast Queensland, the Geelong
region, and Tasmania. 
Mean Amplitudeb Peak Month peak Trough Month trough
Maximum daily duration of vitamin D synthesis (hr/day)
Southeast Queensland 9.6 1.7 11.3 Mid-January 7.9 Mid-July
Geelong region 9.0 2.8 11.8 Mid-January 6.1 Mid-July
Tasmania 8.6 3.5 12.1 Mid-January 5.1 Mid-July
Test for trend p < 0.01 p < 0.01
Vitamin D effective daily dose (consistent with J/m2/day)
Southeast Queensland 3,848 2,639 6,487 Mid-January 1,209 Mid-July
Geelong region 2,642 2,687 5,330 Mid-January –45 Mid-July
Tasmania 2,220 2,538 4,758 Mid-January –319 Mid-July
Test for trend p < 0.01 p < 0.01
aA sinusoidal model was applied to the simulated maximum daily duration of vitamin D synthesis or the simulated
vitamin D effective daily dose and the month of the year; data were included for complete years in which each study was
completed. bHalf the difference between the estimated peak and trough.
would be recommended based on the simu-
lated UV index, there was a high insufficiency
or even deficiency.
Many studies assessing vitamin D status
have been conducted in groups at high-risk of
vitamin D deficiency, such as the elderly,
infants, or veiled women. These data cannot
be generalized to the entire adult Australian
population. In this study we examined popu-
lation-based samples of women < 60 years of
age in three locations covering a broad latitu-
dinal range. The limitations of this study are
that the three populations were recruited with
their own eligibility criteria, which could have
resulted in some selection bias. For example,
the vitamin D insufficiency in the Geelong
region was lower than expected, on the basis
of its latitude. Although we cannot rule out
selection bias, the sample of women in the
Geelong region was recruited from the
Commonwealth Electoral Roll with a high
response rate, and the sample was relatively
large. In addition, we could examine the
effect of latitude and season on 25(OH)D,
but we could not directly determine to what
extent 25(OH)D levels were determined by
other factors such as skin type, dietary intake,
sun behavior, and sun avoidance behavior. A
large percentage of the study participants con-
sidered here were Caucasian. In Geelong,
99% were of European descent, and 81%
reported having a skin type that sunburned
easily or moderately easily (Pasco et al. 2001).
In Tasmania, all participants were Caucasian
(van der Mei et al. 2003). However, even
within Caucasians, skin type could have had
an influence on vitamin D status (van der
Mei et al. 2007). The contribution of dietary
intake of vitamin D to serum 25(OH)D lev-
els was probably small because the intake of
vitamin D in Australia is generally low
(Nowson and Margerison 2002). Indeed, in
the Geelong region dietary intake was low
(1.2 μg/day), and only 7.9% regularly used
vitamin D–containing supplements (Pasco
et al. 2001). In Tasmania, 8.1% of partici-
pants used vitamin D–containing supple-
ments; no association was observed between
serum 25(OH)D and the use of vitamin D–
containing supplements or intake of fish,
milk, eggs, or meat (van der Mei et al. 2007).
For the location-specific simulations of maxi-
mum daily duration of vitamin D synthesis,
vitamin D effective daily dose, and UV index,
changes in ambient conditions (clouds and
aerosols) were not taken into account.
Therefore, our simulated values can be
expected to be higher than the true values. 
Our data confirm that season is an impor-
tant predictor of serum 25(OH)D levels, as
previously reported by Webb et al. (1988).
Season is known to be associated with ambient
ultraviolet radiation; however, it can also reflect
changes in outdoor behavior and amount of
clothing worn. In an in vitro study conducted
in Johannesburg, South Africa (latitude 26°S),
Pettifor et al. (1996) observed no seasonal
variation throughout the year in the formation
of previtamin D3 and vitamin D3 under the
influence of ambient ultraviolet radiation.
However, a clear seasonal pattern in 25(OH)D
levels has been shown at an individual level
(Pettifor et al. 1978). This suggests that the
seasonal variation at an individual level [shown
in an elderly population in Johannesburg by
(Pettifor et al. 1978)] is a consequence of the
increased clothing worn and the decreased
time spent outdoors during winter, rather than
decreased vitamin D–effective UVR reaching
the Earth. Although season was a strong pre-
dictor of serum 25(OH)D, latitude was not as
important as might have been expected based
on the knowledge that ambient ultraviolet
radiation levels (and particularly UVB) gener-
ally decrease with increasing latitude (r = –0.96
for annual ambient UVR) (Gies et al. 1999).
However, the effect of latitude was significant,
and its contribution is likely to be clinically rel-
evant with serum 25(OH)D levels, on average
decreasing 1.0 nmol/L (95% confidence inter-
val, 0.7–1.3 nmol/L) for every degree increase
in latitude. 
A latitudinal gradient in 25(OH)D levels
has been found within a number of countries
such as France (43–55°N) (Chapuy et al.
1997) and Argentina (26–55°S) (Oliveri et al.
2004). Interestingly, across countries in
Europe, a latitudinal gradient in the opposite
direction has been demonstrated among
healthy elderly individuals, with a lower preva-
lence of vitamin D insufficiency in northern
Europe compared with southern Europe (Lips
et al. 2001). One explanation could be that
countries where a negative latitudinal gradient
in 25(OH)D levels was observed might be
more homogeneous in regard to ethnicity and
living and dietary habits (Oliveri et al. 2004).
Across countries, cultural differences in consti-
tutional skin color, outdoor behavior, diet,
and clothing would have played a role, as well
as vitamin D supplementation policies
(Scharla 1998). 
Location-specific estimates of ambient
UVR important for the production of
vitamin D (maximum daily duration of vita-
min D synthesis and vitamin D effective daily
dose) were also a strong determinant of serum
25(OH)D after aligning the seasonal patterns
of those variables with the seasonal pattern of
serum 25(OH)D, although they seemed to
capture similar information as the seasonal
variation in 25(OH)D. A lag period between
the maximum UV dose and the peak
25(OH)D levels has been described previously
(Lucas et al. 2005; Pasco et al. 2004). Here,
using simple sinusoidal models, we observed
that the lag time was approximately twice as
long for Tasmania as for southeast Queensland.
This variation in the number of days by which
serum 25(OH)D lagged behind maximum
daily duration of vitamin D synthesis and vita-
min D effective daily dose may reflect behav-
ioral factors (e.g., amount of clothing worn),
the biological lag between UVR exposure and
25(OH)D synthesis, and/or other location-
specific variables (e.g., actual level of vitamin D
effective daily dose).
Importantly, we found a concerning high
prevalence of vitamin D insufficiency in win-
ter and spring, irrespective of the location
within Australia. In winter/spring, the preva-
lence of insufficiency (≤ 50 nmol/L) was
40.5% in southeast Queensland, 37.4% in the
Geelong region, and 67.3% in Tasmania.
Thus, even residence in a sunny climate, such
as southeast Queensland (27°S), did not pre-
vent vitamin D insufficiency. The same was
found in a healthy adult population in south
Florida (USA; 25°N), where 40% of the
women and 38% of the men had serum
25(OH)D levels < 50 nmol/L at the end of
winter (Levis et al. 2005). These authors
thought that avoidance of sun exposure
because of the heat and increased awareness of
the risk of developing skin cancer were the
underlying reasons for the high prevalence of
insufficiency. 
In Tasmania (43°S), time in the sun was a
predictor of 25(OH)D; although higher levels
of sun exposure are associated with better vita-
min D status, the prevalence of vitamin D
insufficiency in winter/spring was still high
(43%) among the subgroup of people that
were most sun seeking (time in the sun
> 4 hr/day during weekends and holidays).
This suggests that, in winter and spring, the
combination of low ambient UVR and an
increased amount of clothing worn makes it
difficult to achieve an adequate vitamin D sta-
tus (> 50 nmol/L) without a high dietary
intake of vitamin D or vitamin D supplemen-
tation. The current vitamin D and adult bone
health position statement in Australia and New
Zealand indicates that in winter in the south-
ern states, vitamin D levels may be maintained
by approximately 2–3 hr of sunlight exposure
accumulated over a week to the face, arms, and
hands or equivalent surface area (Working
Group of the Australian and New Zealand
Bone and Mineral Society, Endocrine Society
of Australia, Osteoporosis Australia 2005).
Our data suggest that recommended exposure
should be reconsidered and/or that vitamin D
supplementation might be required. 
The question of what an “optimal” level
or range of serum 25(OH)D might be
remains difficult to answer, but suggestions
have been made that the optimal serum
25(OH)D levels may be > 50 nmol/L
(Dawson-Hughes et al. 2005; Hollis 2005).
In our study samples, > 50% of participants
would be vitamin D insufficient in winter if
Vitamin D insufficiency across Australian populations
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the cut-off were 60 nmol/L, and > 70% if the
cut-off were 80 nmol/l. Furthermore, even in
summer, a high percentage of the population
would be insufficient for vitamin D if those
higher cut-off points were used. 
A national cohort study of Caucasian
45-year-old subjects in the United Kingdom
has also reported a high prevalence of hypo-
vitaminosis D in the general population, war-
ranting action at a population, not individual
level (Hypponen and Power 2007). Our data
indicate that even in Australia, a location with
higher ambient UVR, similar problems exist.
Our study findings indicate that sun exposure
protection is recommended in Australia in
some months or regions where vitamin D
insufficiency is high or where vitamin D defi-
ciency exists. A full discussion of the potential
solution to this problem, taking into account
other health effects of UVR such as skin can-
cer, are beyond the scope of this article; how-
ever, policy strategies requiring consideration
include a) the greater promotion of safe sun
exposure while avoiding adverse UVR effects;
b) adequate vitamin D supplementation; and
c) vitamin D fortification of foods. With
regard to the first option, our findings that
maximum daily duration of vitamin D synthe-
sis and vitamin D effective daily dose were
important predictors of serum 25(OH)D indi-
cate that the use of a vitamin D index could
be a valuable additional tool (Kimlin 2004).
Using a vitamin D index in addition to the
UV index for recommending sun exposure to
achieve and/or maintain vitamin D adequacy,
within the range of exposure that avoids
adverse UVR effects, might be useful because
the UV index is weighted by UVB and UVA
wavelengths that produce erythema (sunburn),
which is different from the UVB-only action
spectrum for vitamin D photoproduction.
The present study also particularly emphasizes
that living at low latitude does not prevent vit-
amin D insufficiency and that behavior
(amount of time outside, amount of clothing)
is important. Education should be provided
on these issues. In addition, in Tasmania, a
state with a high level of vitamin D insuffi-
ciency, we had data available on personal sun
exposure. The prevalence of vitamin D insuffi-
ciency in winter and spring was high even
among those who reported high levels of sun
exposure, suggesting that vitamin D levels
should be monitored and that increased
dietary intake of vitamin D, either through
supplements or fortification, should also be
considered. 
In conclusion, we found that vitamin D
insufficiency was common in winter and
spring in three locations in Australia, covering
a latitude of 27°S to 43°S. Season was more
important than latitude in determining serum
25(OH)D. However, both only explained less
than one-fifth of the variation in 25(OH)D
levels, highlighting the importance of behav-
ioral factors. Simulated maximum daily dura-
tion of vitamin D synthesis and vitamin D
effective daily dose were also important pre-
dictors of serum 25(OH)D, indicating that a
location-specific indicator of vitamin D pro-
duction, such as the vitamin D index, could
be useful for recommendations for the
achievement and maintenance of vitamin D
adequacy. Current sun exposure practices and
dietary intake do not seem to fully prevent
vitamin D insufficiency and deficiency, and
consideration should be given to modification
of sun exposure advice or pursuing other
means to achieve vitamin D adequacy.
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